Citigroup Inc Insmed Inc Transaction History

Citigroup Inc

$153 Billion
Q2 2024

A detailed history of Citigroup Inc transactions in Insmed Inc stock. As of the latest transaction made, Citigroup Inc holds 54,939 shares of INSM stock, worth $3.98 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

54,939

Previous 326,566 83.18%

Holding current value

$3.98 Million

Previous $8.86 Million 58.46%

% of portfolio

0.0%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$22.0 - $69.71 $5.98 Million - $18.9 Million	-271,627 Reduced 83.18%	54,939 $3.68 Million
Q1 2024 May 10, 2024	BUY	$25.72 - $29.94 $4.71 Million - $5.49 Million	183,285 Added 127.92%	326,566 $8.86 Million
Q4 2023 Feb 09, 2024	BUY	$23.42 - $31.74 $84,827 - $114,962	3,622 Added 2.59%	143,281 $4.44 Million
Q3 2023 Nov 09, 2023	SELL	$19.86 - $26.93 $146,983 - $199,308	-7,401 Reduced 5.03%	139,659 $3.53 Million
Q2 2023 Aug 10, 2023	SELL	$16.44 - $21.1 $2.88 Million - $3.7 Million	-175,482 Reduced 54.41%	147,060 $3.1 Million
Q1 2023 May 11, 2023	BUY	$16.26 - $21.73 $1.79 Million - $2.39 Million	110,055 Added 51.79%	322,542 $5.5 Million
Q4 2022 Feb 09, 2023	SELL	$16.98 - $23.15 $779,738 - $1.06 Million	-45,921 Reduced 17.77%	212,487 $4.25 Million
Q3 2022 Nov 10, 2022	BUY	$20.88 - $28.21 $1.31 Million - $1.77 Million	62,649 Added 32.0%	258,408 $5.57 Million
Q2 2022 Aug 10, 2022	BUY	$17.07 - $25.71 $2.53 Million - $3.81 Million	148,323 Added 312.68%	195,759 $3.86 Million
Q1 2022 May 12, 2022	SELL	$20.42 - $28.13 $2.79 Million - $3.84 Million	-136,590 Reduced 74.22%	47,436 $1.12 Million
Q4 2021 Feb 10, 2022	BUY	$25.89 - $33.45 $2.22 Million - $2.87 Million	85,694 Added 87.15%	184,026 $5.01 Million
Q3 2021 Nov 10, 2021	BUY	$22.46 - $29.47 $2.21 Million - $2.9 Million	98,332 New	98,332 $2.71 Million

Others Institutions Holding INSM

# of Institutions

447

Shares Held

170M

Call Options Held

5.79M

Put Options Held

5.18M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $9.82B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account